SCHEMBL4650357

SCHEMBL4650357

CC(=O)c1ccccc1NCC(=O)Nc1ccccc1C(=O)O

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.59
KDM4E B2RXH2 5/20 0.56
RAB9A P51151 4/20 0.56
AGTR1 P30556 1/20 0.56
POLB P06746 1/20 0.55
ALDH1A1 P00352 5/20 0.53
HTT P42858 1/20 0.53
LMNA P02545 3/20 0.52
MEN1 O00255 1/20 0.52
L3MBTL1 Q9Y468 2/20 0.51
MAPT P10636 2/20 0.51
CTSK P43235 1/20 0.51
HPGD P15428 3/20 0.51
CYP2C9 P11712 1/20 0.51
SMN1; SMN2 Q16637 3/20 0.50
NPC1 O15118 3/20 0.50
HCAR2 Q8TDS4 1/20 0.50
HSD17B10 Q99714 1/20 0.50
RECQL P46063 1/20 0.49
GAA P10253 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4650402 0.87 POLB (0.52) KMT2AKDM4ERAB9AAGTR1POLB
SCHEMBL4650557 0.87 KDM4E (0.53) KMT2AKDM4ERAB9AAGTR1POLB
SCHEMBL4650759 0.86 KMT2A (0.51) KMT2AKDM4ERAB9AAGTR1POLB
SCHEMBL4650518 0.85 KMT2A (0.50) KMT2AKDM4ERAB9AAGTR1POLB
SCHEMBL4650280 0.85 KMT2A (0.50) KMT2AKDM4ERAB9AAGTR1POLB
SCHEMBL29193536 0.85 KMT2A (0.59) KMT2AKDM4ERAB9AAGTR1POLB
SCHEMBL2627998 0.83 KMT2A (0.59) KMT2AKDM4ERAB9AAGTR1POLB
SCHEMBL4651062 0.82 ALDH1A1 (0.47) KMT2AKDM4ERAB9APOLBALDH1A1
SCHEMBL4650471 0.82 ALDH1A1 (0.47) KMT2AKDM4ERAB9APOLBALDH1A1
SCHEMBL4650312 0.82 ALDH1A1 (0.47) KMT2AKDM4ERAB9APOLBALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101336236-A Anthranilic acid derivatives useful in treating infection with hepatitis c virus WYETH CORP (US) 2008-12-31 CN claimed
EP-1966181-A2 ANTHRANILIC ACID DERIVATIVES USEFUL IN TREATING INFECTION WITH HEPATITIS C VIRUS Wyeth (US) 2008-09-10 EP claimed
WO-2008051244-A2 ANTHRANILIC ACID DERIVATIVES USEFUL IN TREATING INFECTION WITH HEPATITIS C VIRUS WYETH (US) 2008-05-02 WO claimed
CN-101336236-A Anthranilic acid derivatives useful in treating infection with hepatitis c virus WYETH CORP (US) 2008-12-31 CN disclosed
EP-1966181-A2 ANTHRANILIC ACID DERIVATIVES USEFUL IN TREATING INFECTION WITH HEPATITIS C VIRUS Wyeth (US) 2008-09-10 EP disclosed
WO-2008051244-A2 ANTHRANILIC ACID DERIVATIVES USEFUL IN TREATING INFECTION WITH HEPATITIS C VIRUS WYETH (US) 2008-05-02 WO disclosed